- Research article
- Open access
- Published:
METTL3 restricts RIPK1-dependent cell death via the ATF3-cFLIP axis in the intestinal epithelium
Cell Regeneration volume 13, Article number: 14 (2024)
Abstract
Intestinal epithelial cells (IECs) are pivotal for maintaining intestinal homeostasis through self-renewal, proliferation, differentiation, and regulated cell death. While apoptosis and necroptosis are recognized as distinct pathways, their intricate interplay remains elusive. In this study, we report that Mettl3-mediated m6A modification maintains intestinal homeostasis by impeding epithelial cell death. Mettl3 knockout induces both apoptosis and necroptosis in IECs. Targeting different modes of cell death with specific inhibitors unveils that RIPK1 kinase activity is critical for the cell death triggered by Mettl3 knockout. Mechanistically, this occurs via the m6A-mediated transcriptional regulation of Atf3, a transcription factor that directly binds to Cflar, the gene encoding the anti-cell death protein cFLIP. cFLIP inhibits RIPK1 activity, thereby suppressing downstream apoptotic and necroptotic signaling. Together, these findings delineate the essential role of the METTL3-ATF3-cFLIP axis in homeostatic regulation of the intestinal epithelium by blocking RIPK1 activity.
Background
The small intestine epithelium comprises a monolayer of cells organized into distinct structures known as crypts and villi. At the crypt, intestinal stem cells (ISCs) undergo rapid renewal and differentiation, replenishing the stem cell pool and giving rise to differentiated cells (Barker 2014). Homeostasis in the intestinal epithelium relies on continuous renewal and regulated cell death (Okumura and Takeda 2017; Wang et al. 2021). Aberrant increase in cell death is a major contributor to structural disruption in the epithelium, leading to pathological conditions such as inflammatory bowel diseases (IBD) and infectious colitis (Chan 2012; Wang et al. 2022).
It has been reported that intestinal epithelial cells can undergo different types of cell death, including anoikis, apoptosis, necroptosis, ferroptosis and pyroptosis (Patankar and Becker 2020; Subramanian et al. 2020). Receptor-interacting protein kinase (RIPK) 1 is a pivotal protein kinase that mediates both apoptosis and necroptosis (Christofferson et al. 2014; Xu et al. 2021). Upon activation, RIPK1 interacts with FADD, TRADD, and caspase 8 to form the complex II a, promoting RIPK1-dependent apoptosis (Micheau and Tschopp 2003). In the presence of caspase inhibitors, activated RIPK1 binds to RIPK3 to form the complex II b, leading to the activation of Mixed-lineage kinase domain-like protein (MLKL) and subsequent necroptosis (Yuan et al. 2019). In the small intestinal epithelium, inhibition of RIPK1 kinase activity suppresses intestinal epithelial cell death and prevents Paneth cell loss in the mice with combined RelA, c-Rel, and RelB deficiency in IECs or IEC-specific knockout (KO) of NEMO (Vlantis et al. 2016). Conversely, specific deficiency of Ripk1 in IECs leads to extensive apoptosis and necroptosis through its scaffold function but not kinase function (Dannappel et al. 2014; Takahashi et al. 2014). Although post-translational modification regulation of RIPK1 has been elucidated in the small intestinal epithelium (Chan 2014), the role of mRNA modifications in intestinal cell death is poorly understood.
N6-adenomethylation (m6A) is the most prevalent post-transcriptional modification of eukaryotic RNAs, constituting 0.4%~0.6% of all adenosine nucleotides in mammalian RNAs (Frye et al. 2018). m6A methylation is facilitated by a multi-subunit m6A methyltransferase complex, composed of methyltransferase-like 3 (METTL3) and 14 (METTL14) (Liu et al. 2014). Removal of m6A methylation is orchestrated by RNA demethylases, including FTO (Fat mass and obesity-associated protein) and ALKBH5 (AlkB homolog 5) (Jia et al. 2011; Zheng et al. 2013). Various “reader” proteins mediate the execution of m6A functionality, such as RNA stability, splicing, nuclear export, or translation (Zaccara et al. 2019; Zhao et al. 2017). Emerging evidence underscores the indispensability of m6A modification in embryonic development, organ growth, and stem cell maintenance (Geula et al. 2015; Li et al. 2018; Liu et al. 2023). m6A function in intestine is also appreciated, including ISCs maintenance, epithelial homeostasis and regeneration (Du et al. 2022; Han et al. 2020; Liu et al. 2023; Zhang et al. 2022). However, the role of Mettl3-mediated m6A in regulating cell death of the small intestinal epithelium remains elusive.
Here, we report that Mettl3-mediated m6A modification is involved in both apoptosis and necroptosis in the small intestinal epithelium. Using mouse and organoid models, we demonstrate that the METTL3-ATF3-cFLIP-RIPK1 axis balances cell survival and death. Mechanistically, ATF3, acting downstream of Mettl3, stimulates the expression of the anti-cell death protein cFLIP, leading to inhibition of RIPK1 and thus cell survival.
Results
Mettl3 deletion induces death of intestinal epithelial cells
In our previous study, we unveiled that METTL3 plays a crucial role in maintaining ISCs in the intestinal epithelium. IEC-specific deletion of Mettl3 compromises stemness without affecting proliferation (Liu et al. 2023). Among the Mettl3-mediated m6A modified mRNAs, four encoded transcriptional factors that regulated stemness gene expression in ISCs. Their ectopic expression restored stemness gene expression but could not rescue cell death (Liu et al. 2023). These findings suggest that, beyond its role in stemness regulation, Mettl3-mediated m6A methylation is also critical in cell death regulation. Indeed, gene ontology (GO) analysis revealed the genes involved in programmed cell death pathways were enriched among the up-regulated genes in Mettl3-KO IECs (Fig. S1A).
Various programmed cell death mechanisms have been identified in IECs. In addition to apoptosis, necroptosis, pyroptosis, and ferroptosis have been reported in the intestinal epithelium (Patankar and Becker 2020). We first examined the mode of cell death occurring in the Mettl3-KO intestinal epithelium. The hallmarks of apoptosis and necroptosis, cleaved caspase3 (c-caspase 3) and phosphorylated MLKL (p-MLKL), were observed in Mettl3-KO intestinal epithelium at day 4 and day 6 (Fig. S1B, C). Notably, both necroptotic and apoptotic cells were enriched in the crypt region, possibly due to the enriched expression pattern of METTL3 in the crypts (Liu et al. 2023). Based on the cell location and LYZ co-staining, a substantial number of necroptotic and apoptotic cells were found in both stem cells and transient amplifying (TA) cells but not Paneth cells (Fig. 1A, B and Fig. S1D, E). Consistently, the transcriptional levels of genes associated with necroptosis and apoptosis were upregulated (Fig. 1C, D), which is confirmed by qPCR analysis (Fig. 1E). Immunoblotting further validated the activation of apoptotic and necroptotic pathways (caspase3, RIP3 and MLKL activation) in crypts and organoids derived from Mettl3-KO mice (Fig. 1F and Fig. S1F). Transmission electron microscopy also revealed subcellular features of cell death, including apoptotic body, necrosis-like swelling mitochondria and a low electronic condensation of the cytoplasm in Mettl3-KO crypt cells (Fig. 1G). Additionally, apoptotic and necroptotic signals were detected in the same epithelial cell as shown by p-MLKL and c-caspase3 co-staining (Fig. 1H). Further examination of genes related to apoptosis and necroptosis, such as Casp8 and Ripk1 (Christofferson et al. 2014; Dannappel et al. 2014; Guo et al. 2016), revealed reduced m6A modification and elevated gene expression upon Mettl3-KO (Fig. S1G). Together, these observations indicate that Mettl3 depletion triggered extensive apoptosis and necroptosis of intestinal epithelial cells.
Mettl3 deletion-induced cell death depends on RIPK1
To discern which cell death mode ultimately leads to death of Mettl3-KO epithelial cells, we tested the effect on organoids death of various cell death inhibitors, targeting apoptosis, necroptosis, and pyroptosis, respectively. The RIPK1 inhibitor necrostatin-1 (Nec-1) reduced cell death of Mettl3-KO organoids, although the pan-caspase inhibitor z-VAD-FMK (z-VAD), the RIPK3 inhibitor GSK'872, or the GSDMD inhibitors disulfiram and Ac-FLTD-CMK had no effect (Fig. 2A, B and Fig. S2A, B). Consistently, Nec-1 blocked Mettl3 deletion-induced activation of caspase3, MLKL and RIPK1 (Fig. 2C and Fig. S2C) (Degterev et al. 2008), indicating Nec-1 might rescue cell death by impeding both necroptosis and apoptosis. Additionally, bulk RNA-seq analysis showed that Nec-1 treatment decreased the expression of cell death genes in Mettl3-KO organoids (Fig. S2D). Besides, Nec-1 restrained signaling pathways associated with cell death and inflammation in Mettl3-KO organoids, such as TNF production, NF-κB activity and the apoptotic process (Fig. 2D). These data together suggest that Mettl3 could regulate apoptotic and necroptotic signaling via a RIPK1-dependent mechanism.
Mettl3 regulates ATF3 mRNA stability
Given that METTL3 regulates apoptosis and necroptosis mainly through a RIPK1-dependent manner in IECs, we explored the mechanism how METTL3 regulates RIPK1-dependent cell death. To search for candidates regulated by Mettl3-mediated m6A modification, we integrated the RNA-seq, MeRIP-seq and single-cell RNA-seq (scRNA-seq) data for comprehensive analysis. As transcription regulation is mainly involved in altered m6A-methylated transcripts (Liu et al. 2023), we predicted upstream transcriptional factors by analyzing the differentially expressed genes associated with cell death using the chEA3 online tool (Fig. S3A). By combining the MeRIP-seq data, RNA-seq data and qPCR confirmation, we found that 4 TFs, Atf3, Csrnp1, Fosb (Liu et al. 2023) and c-Jun, exhibited reduced m6A methylation and low mRNA expression in Mettl3 KO cells (Fig. 3A-C and Fig. S3B). Csrnp1 transcript exhibited low expression in the intestinal epithelium (Fig. S3C), and Fosb mainly regulated stemness but not cell death (Liu et al. 2023).
Therefore, we focused on Atf3 and c-Jun, and conducted knockout or overexpression assay to explore their function in organoids (Fig. S3D-F). Organoids subjected to in vitro irradiation conditions undergo organoid damage and cell apoptosis (Kim et al. 2022; Morral et al. 2024). Although Atf3-KO and c-Jun-KO organoids displayed normal morphology, upon irradiation, the survival rate and budding number of these organoids decreased, suggesting that Atf3 and c-Jun play a role in suppressing cell death (Fig. 3D). Conversely, Atf3-overexpression partially restored the survival rate and spheroid size in Mettl3-KO organoids (Fig. 3E). Moreover, Atf3-overexpressing organoids showed reduced levels of cleaved-caspase3, p-MLKL, p-RIPK1 and p-RIPK3 compared to Mettl3-KO organoids (Fig. 3F and Fig. S3G), indicating that Atf3 could inhibit RIPK1-dependent apoptosis and necroptosis. Meanwhile, the total protein level of RIPK3 and MLKL were slightly upregulated upon ATF3 overexpressed, consistent with previous study that ATF3 could regulate the expression of Ripk3 and Mlkl (Inaba et al. 2023). In contrast, the organoids that overexpressed c-Jun exhibited the opposite effect (Fig. 3E). This may attribute to the dual function of c-Jun in both cell survival and cell death (Eferl and Wagner 2003).
ATF3 upregulates cFLIP to suppress cell death
To further investigate the mechanism by which ATF3 regulates RIPK1-dependent cell death signaling in the intestinal epithelium, we performed ChIP-seq to identify ATF3 downstream targets. ATF3 binding was enriched in the DNA motif GG/AGGCGGG/A (Fig. S4A), and its target genes were implicated in the processes of apoptotic process and DNA damage (Fig. 4A). As ATF3 weakly bound to the Ripk1 gene loci (Fig. S4B), by combining Atf3 targets and Mettl3-KO-induced differentially expressed cell death genes, we identified Cflar (Fig. S4C), which encoded cFLIP (Cellular FLICE-like inhibitory protein), a suppressor of RIPK1-mediated cell death complex (Davidovich et al. 2023; Delanghe et al. 2020; Silke and Strasser 2013). Indeed, ATF3 bound to the Cflar gene, and the loci were correlated with the accessible chromatin, as indicated by assay for transposase-accessible chromatin with sequencing (ATAC-seq) analysis (Fig. 4B, C). The expression of Cflar was upregulated in Atf3-OE organoids and downregulated in Mettl3-KO ISCs and crypt cells (Fig. 4D and Fig. S4D, E), implying the Cflar was positively regulated by ATF3. More importantly, compared to wild-type organoids, Cflar-KO organoids exhibited a lower survival rate, fewer budding number and elevated c-caspase3 (Fig. 4E and Fig. S4F). Furthermore, Cflar-overexpression partially rescued the survival rate and spheroid size of Mettl3-KO organoids (Fig. 4F). Co-immunoprecipitation assay revealed cFLIP interacted with RIPK1 (Fig. 4G). Together, these data indicate that cFLIP, as a target of ATF3, interacts with RIPK1 and participates in Mettl3 KO-induced cell death in the intestinal epithelium.
Disruption of RIPK1 activity rescues Mettl3 KO-induced cell death
To illustrate the function of Ripk1 in Mettl3-KO mice, we knocked down Ripk1 in organoids derived from Vil-CreERT2;Mettl3fl/fl mice. Since Ripk1 knockdown partially rescued cell survival and increased budding number in Mettl3-KO organoids (Fig. S5A), we assessed whether genetic inactivation of RIPK1 prevents intestinal epithelial cell death in Mettl3-deficient mice. We crossed Vil-CreERT2;Mettl3fl/fl mice with Ripk1K45A-knockin mice, which harbor a RIPK1 kinase-dead K45A mutation (Fig. S5B) (Liu et al. 2017). Genetic inactivation of RIPK1 delayed the death time from 7~11 days to 10~13 days (Fig. 5A). Additionally, the crypt elongation and the epithelial structure were partially restored (Fig. 5B and Fig S5C). Moreover, Mettl3-KO mice harboring RIPK1(K45A) exhibited less c-caspase 3 and p-MLKL cells compared to Mettl3-KO mice (Fig. 5C, D and Fig. S5D, E). Therefore, these findings suggest that RIPK1 plays a critical role in Mettl3 KO-induced intestinal epithelial cell death.
Discussion
It has been reported that m6A modification plays an important role in regulation of stemness of ISCs and regeneration of the intestinal epithelium (Han et al. 2020; Liu et al. 2023). In this study, we found that METTL3-mediated m6A modification is crucial for regulating cell death of the small intestinal epithelial cells, thereby ensuring the maintenance of intestinal epithelial homeostasis (Fig. 6), which is in accordance with the role of m6A modification in preserving colon epithelial cell survival by targeting apoptosis (Du et al. 2022; Zhang et al. 2022). Interestingly, we observed that Mettl3-deficiency could induce both apoptosis and necroptosis in small intestinal epithelial cells. Moreover, we found that both apoptosis and necroptosis markers were in a minimal fraction of the same intestinal epithelial cells, indicating that these cells may even undergo concurrent apoptosis and necroptosis. It is worthy of further investigation as to how apoptosis and necroptosis take place in single cell. Inhibition of RIPK1 could prevent Mettl3-KO-induced cell death, whereas the pan-caspase inhibitor or RIPK3 inhibitor did not, demonstrating the essential role of RIPK1 in Mettl3-KO induced cell death. That is consistent with the previous report that RIPK1 could mediate apoptosis and necroptosis via TNFR1 signaling cascades (Xu et al. 2021).
IECs have been reported to undergo different types of cell death (Patankar and Becker 2020; Subramanian et al. 2020). TAK1 and caspase 8 are identified as pivotal regulators of IEC apoptosis versus necroptosis programs downstream of TNFR1 (Fritsch et al. 2019; Geng et al. 2017; Newton et al. 2019). TAK1-activated NF-κB signaling is required for cell survival (Kajino-Sakamoto et al. 2008; Nenci et al. 2007; Pasparakis 2009; Steinbrecher et al. 2008; Sträter and Möller 2000). Their deletion triggers the apoptotic cascade through the recruitment of FADD and caspase 8 to TNF receptor complex (Patankar and Becker 2020). Ablation of FADD or caspase 8 in IECs leads to non-apoptotic cell death and spontaneous gut inflammation, which can be reversed by further knockout of RIPK3 (Günther et al. 2011; Welz et al. 2011). These results indicate that FADD or caspase 8 deficiency causes intestinal inflammation by sensitizing IECs to RIPK3-dependent necroptosis. TAK1 has also been shown to enhance FLIP degradation, facilitating the formation of the RIPK1-FADD-caspase 8 complex, leading to apoptosis (Guo et al. 2016). Moreover, an optimal level of caspase 8 activity is essential for maintaining IEC stability: high activation initiates apoptosis while low activity leads to necroptosis (Ruder et al. 2018). Besides METTL3-ATF3-cFLIP-RIPK1 axis, we also observed that Mettl3 deletion induces an increased expression of Ripk1 and Casp8 (Fig S1 F, G). The upregulation of total Casp8 and Ripk1 expression resulting from Mettl3 knockout may induce increased apoptosis and partially inhibit necroptosis. However, necroptosis still occurs in the intestinal epithelial cells by combining the effects of the METTL3-ATF3-cFLIP-RIPK1 axis. Moreover, METTL3 could regulate Ripk1 gene expression through m6A modifications, as well as inhibit RIPK1 activation via the METTL3-ATF3-cFLIP-RIPK1 axis.
We identified two transcriptional factors regulated by METTL3-mediated m6A modification, Atf3 and c-Jun, which belong to the members of the activator protein-1 (AP-1) family. AP-1 transcription factors regulate cell proliferation, cell survival and cell death (Shaulian and Karin 2002). ATF3 was shown to maintain intestinal barrier regeneration and IEC survival (Yang et al. 2009; Zhou et al. 2017), while it also promotes IEC apoptosis by working with p53 in Crohn’s disease (Gu et al. 2018). Here, we demonstrated that Mettl3-mediated m6A modification is essential for Atf3 mRNA stability. We further showed that ATF3 prevents apoptosis and necroptosis by upregulating cFLIP, a suppressor of RIPK1. Therefore, ATF3 plays a crucial role in safeguarding intestinal barrier under stress. c-Jun knockout also enhanced cell death in intestinal organoids, supporting its role in mediating Mettl3-KO-induced cell death. However, c-Jun overexpression also triggered cell death in organoids, which is consistent with the early report (Bossy-Wetzel et al. 1997). These data emphasize the context-dependent role of c-Jun in cell proliferation and death (Shaulian and Karin 2001, 2002), which need further investigation.
Materials and methods
Mice
Mettl3fl/fl mice were from Dr. Wei Li (Institute of Zoology, CAS) (Xu et al. 2017), and Vil-CreERT2 mice were a gift from Dr. Sylvie Robine (Institut Curie-CNRS) (Ireland et al. 2004). Ripk1K45A mice from Dr. Xiao-Dong Wang (National Institute of Biological Sciences) (Liu et al. 2017). Above mice were crossed to generate Vil-CreERT2;Mettl3fl/fl mice and Vil-CreERT2;Mettl3fl/fl;Ripk1K45A mice. Male mice aged 2~4 months were used in this study. All animal studies were conducted in accordance with the relevant guidelines and under the approval of the Institutional Animal Care and Use Committee of Tsinghua University.
For Cre induction in mice intestinal epithelium, Vil-CreERT2;Mettl3fl/fl mice and Vil-CreERT2;Mettl3fl/fl;Ripk1K45A mice were intraperitoneally injected at a dose of 100 mg/kg body mass tamoxifen (Sigma, T5649) in corn oil for 4 consecutive days. Mettl3fl/fl mice and Mettl3fl/fl;Ripk1K45A mice were treated with an equal amount of tamoxifen as corresponding control group.
Isolation of intestinal crypts and organoid culture
Mouse small intestinal crypts were isolated and cultured following the established procedures (Qi et al. 2017). Briefly, the mouse intestine was longitudinally cut and washed with cold PBS. After carefully removing villi, small intestine pieces were incubated in PBS containing 2 mM EDTA for 30 min on ice. The pieces were then vigorously suspended in cold PBS, and the mixture was filtered through a 70 μm cell strainer (BD Biosciences). The crypt fraction was enriched by centrifugation. Then the crypts were embedded in Matrigel (Corning, #356,231) and seeded on 24-well plate. After polymerization, the crypts were cultured in ENR medium (Advanced DMEM/F12 containing EGF (50 ng /mL, Invitrogen), Noggin (100 ng /mL, OrganRegen) and R-spondin1 (500 ng /mL, OrganRegen), Penicillin/Streptomycin, GlutaMAX-I, N2, B27 and N-acetylcysteine (Sigma-Aldrich). For passaging, the organoids were suspended with cold PBS, centrifuged and then re-embedded in fresh Matrigel before seeding on a plate.
To induce Mettl3 ablation in the organoids derived from Vil-CreERT2;Mettl3fl/fl mice, 500 nM 4-Hydroxytamoxifen (4-OHT) was added to the ENR culture medium for 2 days. For spheroid colony formation, alive RFP+ cells (which were infected with virus) were sorted by flow cytometry, then embedded in fresh Matrigel, cultured in expansion medium (ENR culture medium plus 2.5 µΜ CHIR-99,021, 10% Wnt-3a conditional medium and 6.67 µM blebbistatin).
Virus production and organoid infection
Retrovirus and lentivirus were used for overexpressing Atf3, c-Jun and Cflar in the organoids, the corresponding plasmids were pMSCV-loxp-dsRed-loxp-eGFP-Puro-WPRE (Addgene, 32,702) and pLVX-IRES-Puro (Clontech, 632,183). Mouse Atf3, c-Jun and Cflar cDNAs were constructed into these two vectors for further overexpression experiment.
Retrovirus, lentivirus and recombinant adeno-associated virus (AAV) were produced as previously described (Koo et al. 2011; Li et al. 2021; Liu et al. 2021). Before virus infection, organoids underwent a two-day culture with expansion medium supplemented with 10 mM nicotinamide. Subsequently, the organoids were digested to cell pellet using TrypLE (Gibco, 12,604,021). The cell pellet was re-suspended in expansion medium supplemented with 10 µg/mL polybrene (Macgene, MC032), and mixed with the virus. The cell-virus mixture (250 µL) in expansion medium plus polybrene was then added to pre-solidified Matrigel and incubated overnight at 37 °C. Next day, the medium was removed, and the virus was washed with warm PBS. Following this, a 10 µL Matrigel overlay was applied, and the organoids were cultured in expansion medium.
Vil-CreERT2;Mettl3fl/fl organoids were prepared for retrovirus and lentivirus infection, and the culture medium was replaced with ENR supplemented with 2 µg/mL puromycin at day 2 post-infection. Once the organoids exhibited normal growth under puromycin selection, both protein expression and Mettl3-KO was induced using 4-OHT (0.5µM, Sigma, H7904). Vil-CreERT2;Rosa26loxp−stop−loxp−Cas9−EGFP organoids were prepared for recombinant AAV infection and pretreated with 4-OHT to induce Cas9 expression. The sgRNA sequences are listed in Supplementary Table S1.
Image acquisition and analysis of organoid cell death
For cell death inhibitor treatment, Vil-CreERT2;Mettl3fl/fl organoids were treated with EtOH or 4-OHT for 2 days. In the 4-OHT treatment group, DMSO or 10 µM z-VAD (Selleck, S7023), 10 µM GSK’872 (Selleck, S8465), 10 µM Necrostatin-1 (Selleck, S8037), 5 µM Disulfiram (MCE, HYB0240), 10 µM Ac-FLTD-CMK (MCE, HY-111,675), were added to the culture medium. At day 4 post-treatment, 1 µg/mL propidium iodide (PI) dye was added and incubated for 30 min. Subsequently, on the 4, 5, 6 days post-treatment, fluorescent microscopy was employed to observe the PI staining within the organoids.
Tyramide signal amplification (TSA)-mediated immunofluorescence and H&E staining
A fluorescence kit based on TSA technology was employed following the manufacturer’s instruction (Recordbio Biological Technology, RC0086-23R). Intestinal tissues were fixed in 10% formalin at room temperature for 2 h, dehydrated in 20% sucrose solution overnight, and subsequently embedded for cryo-sections. For antigen retrieval, sections underwent boiling at 100 °C for 10 min in a pH 6.0 citric acid buffer solution within a microwave-enabled retrieval chamber. To inhibit endogenous peroxidase activity, sections were treated with a 3% hydrogen peroxide solution at room temperature for 15 min. 3% bovine serum albumin was applied to block non-specific signals for 30 min at room temperature. The sections were then incubated overnight at 4 °C with the primary antibody. Next day, the sections were incubated with horseradish peroxidase-conjugated secondary antibody (anti-mouse or anti-rabbit) for 50 min at room temperature. Following the incubation, fluorescence labeling was achieved by treating the sections with TYR520 fluorescent dye for 10~15 min. For cleaved-caspase 3 (1:300, CST, 9664S) and p-MLKL (1:1600, Abcam, ab196436) co-staining, repeat previous steps from the antigen retrieval, and switch to TYR570 fluorescent dye for p-MLKL. After incubation for fluorescent dye, DAPI was staining for another 15 min.
For hematoxylin-eosin staining, the intestinal tissues were fixed in 4% paraformaldehyde at room temperature overnight, then sequentially in 70%, 80%, 90%, 95%, and 100% ethanol, followed by further dehydration in xylene. The sample was placed in paraffin, immersed for 2 h, and subsequently embedded to create paraffin-sections. Paraffin-sections were automatically stained using a stainer integrated workstation (Leica ST5020-CV5030), the time of hematoxylin staining was 30s.
Transmission electron microscopy (TEM)
The mice intestine was longitudinally opened and cut into approximately 5 mm pieces, followed by fixation in 2.5% glutaraldehyde in PBS immediately. After embedding in Epon Araldite, ultrathin sections were sliced along the crypt-villus axis and analyzed using a Hitachi HT-7800 TEM.
Flow cytometry
Organoids infected with retrovirus were incubated in TrypLE (Gibco, 12,604,021) for 20 min at 37 oC to obtain single-cell suspension. The dissociated cells were subsequently filtered through a 40 μm cell strainer (BD), staining with 4’,6-Diamidino-2-Phenylindole (DAPI, Invitrogen, D1306). Infected cells (DAPI−RFP+) were sorted using flow cytometry (MoFlo Astrios EQ, Beckman).
Quantitative real-time PCR (qRT–PCR)
Total RNA was extracted from tissues or organoids using the RaPure Total RNA Kit (Magen, R4011), and cDNA was synthesized using cDNA Synthesis SuperMix (Novoprotein, E047-01A). qRT–PCR was conducted in triplicates on a LightCycler 480 (Roche) using NovoStart®SYBR qPCR SuperMix Plus (Novoprotein, E096-01A) with Gapdh as the reference gene. Data were analyzed according to the 2−ΔΔCT method. Primer sequences are listed in Table S2.
Immunoblotting
Protein lysates were prepared from intestinal epithelial crypts or organoids. Cells were lysed in RIPA buffer (Beyotime, P0013B) with protease inhibitors (Roche, 04693132001), PMSF (Beyotime, ST506) and phosphatase inhibitor (Solarbio, P1260). 40 µg of total protein was separated with 10% SDS-PAGE gel under denaturing conditions and were transferred to nitrocellulose membranes (PALL, 66,485). Following blocking, the membranes were incubated with primary antibodies and subsequently with secondary anti-rabbit or anti-mouse conjugated antibodies. Relative protein intensities were calculated by Image Lab software (Version 6.1), the relative level of total proteins was normalized to GAPDH and the relative level of phosphorylated proteins was normalized to the corresponding total protein.
The following primary antibodies were used: rabbit anti-METTL3 (1:1000, Abcam, ab195352), ATF3 (Abcam, ab207434), c-JUN (Abcam, ab32137), MLKL (1:1000, Abcam, ab172868), p-MLKL (1:1000, Abcam, ab196436), caspase-3 (1:1000, 350,192, Zenbio), cleaved caspase-3 (1:1000, CST, 9664S), cFLIP (1:1000, CST, 56,343S), p-RIPK3 (1:500, CST, 93,654), RIPK3 (1:1000, abcam, ab62344), p-RIPK1 (1:500, CST, 65,746), RIPK1 (1:1000, Bioss, bs-5805R), mouse anti-Tubulin (1:1000, MBL, PM054-7) and GAPDH (1:1000, MBL, M171-7).
Immunoprecipitation
Co-immunoprecipitation conducted using Dynabeads Protein A/G immunoprecipitation Kit (10007D, Invitrogen) following the manufacturer’s instruction. For each sample, 10 µL Dynabeads Protein A and 10 µL Dynabeads Protein G were transferred to a low-binding tube, placed on a magnet, and the supernatant was removed. The beads were then resuspended in 200 µL Binding & Washing Buffer containing 1 µg of anti-rabbit-IgG (CST, 7074) or rabbit anti-cFLIP (CST, 56,343S) per sample, followed by a 4-hr incubation with rotation at 4 °C. The Dynabeads-antibody complex was separated with a magnet and washed using 200 µL Ab Binding & Washing Buffer. Lentivirus-infected organoids, either control or overexpressing Cflip, were lysed in 300 µL ice-cold IP lysis buffer (10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.5% NP-40, 1 mM EDTA, 1mM PMSF, 50 mM NaF, 2 mM Na3VO4, protease inhibitor cocktails (04693132001, Roche)) for 1 h. After centrifugation at 13,000 rpm for 10 min. 30 µL soluble supernatants were harvested as input after preclearing, and the remaining soluble supernatants were immunoprecipitated with corresponding antibody binding Dynabeads with rotation overnight at 4 ℃. The immunoprecipitants were washed three times with PBS. The Dynabeads-antibody-antigen complex was gently resuspended in 30 µL loading buffer and analyzed by western blot.
RNA-seq
Total RNA was extracted with RNeasy Mini Kit (QIAGEN) according to the manufacturer’s instruction. Bulk RNA-seq was performed using the Illumina Hiseq X Ten platform and analyzed as previously described (Liu et al. 2023).
CUT&Tag ChIP-seq
Alive lentivirus-infected organoids overexpressing Atf3 were sorted and collected into 500 uL PBS, cells conducted ChIP-seq following the NovoNGS CUT&Tag 3.0 High-Sensitivity Kit (Novoprotein, H259-YH01) and the lysates were incubated with anti-ATF3 antibody (1:100, Abcam, ab207434) at 4 ℃ overnight. DNA extracted using Tagment DNA Extract Beads was used as a templet, and amplification was performed with 2X KAPA HIFI HotStart polymerase (KAPA, KK2601). The library was purified with 1.4X AMPure beads and sequenced with the Illumina Novaseq 6000.
ChIP-seq analysis
HISAT2 was used to align the sequences to the mouse genome and generate bam files. PCR duplicates were removed using Picard tools, and Deeptools (3.3.1) bamCoverage (CPM normalized and extended reads) was applied to generate bigwig files from bam files. MACS2 (v2.2.5) conducted peak calling and generated bed files from aligned reads. HOMER (v4.10.0) annotatePeaks.pl was used for peak annotation. Visualization of the binding peaks from bigwig files was performed using IGV (2.6.2). The motif of ATF3 was identified using findMotifsGenome.pl from HOMER.
Gene ontology (GO) analysis
Genes meeting the criteria of P < 0.05 and |log2FC|≥1 were selected for Gene ontology (GO) analysis. The analysis was conducted using the web tool DAVID (http://david.adcc.ncifcrf.gov/), and GO terms with P < 0.05 were considered statistically significant. Venn diagrams were created using online venn diagram (https://bioinformatics.psb.ugent.be/webtools/Venn//).
Methylated RNA immunoprecipitation (MeRIP)-seq, ATAC-seq and Single cell RNA sequencing (scRNA-seq) analysis
A dataset (GSE186917) of control and Mettl3-KO was employed in our research (Liu et al. 2023). We conducted visualizations of m6A level and the expression profile of Casp8, Ripk1, Atf3, c-Jun, Csrnp1 and Fosb using the original processing results obtained from MeRIP-seq and scRNA-seq data of control and Mettl3-KO mice (GSE186917). Additionally, the binding peak of Cflip was visualized based on the ATAC-seq data.
Statistics
All experiments were independently repeated with at least three biological replicates. Statistical analysis was performed with Graphpad Prism (version 10). Data shown in graphs represent mean ± SD as indicated in the figure legends. Unpaired two-tailed t-test, one-way ANOVA, and two-way ANOVA analysis was used to compare differences as indicated in the figure legends.
Availability of data and materials
The RNA-seq and ChIP-seq data generated in this study are publicly available through the Gene Expression Omnibus with the accession code GSE262282 (cut tag ChIP-seq and RNA-seq). The scRNA-seq data, m6A-seq data and bulk RNA-seq data (GSE186917) was used to analyze the expression pattern of Atf3, c-Jun, Csrnp1 and Fosb, and m6A modification and expression level of Casp8 and Ripk1 (Liu et al. 2023). All codes that the main steps of the analysis and data are available from the corresponding author under request.
Abbreviations
- IECs:
-
Intestinal epithelial cells
- ISCs:
-
Intestinal stem cells
- IBD:
-
Inflammatory bowel diseases
- RIPK:
-
Receptor-interacting protein kinase
- MLKL:
-
Mixed-lineage kinase domain-like protein
- m6A:
-
N6-adenomethylation
- METTL3:
-
Methyltransferase-like 3
- METTL14:
-
Methyltransferase-like 14
- FTO:
-
Fat mass and obesity-associated protein
- ALKBH5:
-
AlkB homolog 5
- GO:
-
Gene ontology
- TA:
-
Transient amplifying
- Nec-1:
-
Necrostatin-1
- z-VAD:
-
z-VAD-FMK
- scRNA-seq:
-
Single-cell RNA sequencing
- cFLIP:
-
Cellular FLICE-like inhibitory protein
- ATAC-seq:
-
Assay for transposase-accessible chromatin with sequencing
- AP-1:
-
Activator protein-1
- 4-OHT:
-
4-hydroxytamoxifen
- AAV:
-
Adeno-associated virus
- TSA:
-
Tyramide signal amplification
- TEM:
-
Transmission electron microscopy
- DAPI:
-
4’,6-Diamidino-2-Phenylindole
- MeRIP-seq:
-
Methylated RNA immunoprecipitation sequencing
References
Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15(1):19–33. https://doi.org/10.1038/nrm3721.
Bossy-Wetzel E, Bakiri L, Yaniv M. Induction of apoptosis by the transcription factor c‐Jun. EMBO J. 1997;16(7):1695–709. https://doi.org/10.1093/emboj/16.7.1695.
Chan FK. Fueling the flames: mammalian programmed necrosis in inflammatory diseases. Cold Spring Harb Perspect Biol. 2012;4(11):a008805. https://doi.org/10.1101/cshperspect.a008805.
Chan FK. Cell biology: a guardian angel of cell integrity. Nature. 2014;513(7516):38–40. https://doi.org/10.1038/513038a.
Christofferson DE, Li Y, Yuan J. Control of life-or-death decisions by RIP1 kinase. Annu Rev Physiol. 2014;76:129–50. https://doi.org/10.1146/annurev-physiol-021113-170259.
Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature. 2014;513(7516):90–4. https://doi.org/10.1038/nature13608.
Davidovich P, Higgins CA, Najda Z, Longley DB, Martin SJ. cFLIP(L) acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes. Cell Rep. 2023;42(12): 113476. https://doi.org/10.1016/j.celrep.2023.113476.
Degterev A, Hitomi J, Germscheid M, Ch’ IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4(5):313–21. https://doi.org/10.1038/nchembio.83.
Delanghe T, Dondelinger Y, Bertrand MJM. RIPK1 kinase-dependent death: a Symphony of Phosphorylation events. Trends Cell Biol. 2020;30(3):189–200. https://doi.org/10.1016/j.tcb.2019.12.009.
Du J, Sarkar R, Li Y, He L, Kang W, Liao W, et al. N(6)-adenomethylation of GsdmC is essential for Lgr5(+) stem cell survival to maintain normal colonic epithelial morphogenesis. Dev Cell. 2022;57(16):1976–e1948. https://doi.org/10.1016/j.devcel.2022.07.006.
Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3(11):859–68. https://doi.org/10.1038/nrc1209.
Fritsch M, Günther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575(7784):683–7. https://doi.org/10.1038/s41586-019-1770-6.
Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361(6409):1346–9. https://doi.org/10.1126/science.aau1646.
Geng J, Ito Y, Shi L, Amin P, Chu J, Ouchida AT, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun. 2017;8(1):359. https://doi.org/10.1038/s41467-017-00406-w.
Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, et al. Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science. 2015;347(6225):1002–6. https://doi.org/10.1126/science.1261417.
Gu L, Ge Z, Wang Y, Shen M, Zhao P. Activating transcription factor 3 promotes intestinal epithelial cell apoptosis in Crohn’s disease. Pathol Res Pract. 2018;214(6):862–70. https://doi.org/10.1016/j.prp.2018.04.013.
Günther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature. 2011;477(7364):335–9. https://doi.org/10.1038/nature10400.
Guo X, Yin H, Chen Y, Li L, Li J, Liu Q. TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints. Cell Death Dis. 2016;7(9):e2381. https://doi.org/10.1038/cddis.2016.294.
Han B, Yan S, Wei S, Xiang J, Liu K, Chen Z, et al. YTHDF1-mediated translation amplifies wnt-driven intestinal stemness. EMBO Rep. 2020;21(4): e49229. https://doi.org/10.15252/embr.201949229.
Inaba Y, Hashiuchi E, Watanabe H, Kimura K, Oshima Y, Tsuchiya K, et al. The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice. Nat Commun. 2023;14(1):167. https://doi.org/10.1038/s41467-023-35804-w.
Ireland H, Kemp R, Houghton C, Howard L, Clarke AR, Sansom OJ, et al. Inducible cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology. 2004;126(5):1236–46. https://doi.org/10.1053/j.gastro.2004.03.020.
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885–7. https://doi.org/10.1038/nchembio.687.
Kajino-Sakamoto R, Inagaki M, Lippert E, Akira S, Robine S, Matsumoto K, et al. Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J Immunol. 2008;181(2):1143–52. https://doi.org/10.4049/jimmunol.181.2.1143.
Kim O-H, Kang G-H, Hur J, Lee J, Jung Y, Hong I-S, et al. Externalized phosphatidylinositides on apoptotic cells are eat-me signals recognized by CD14. Cell Death Differ. 2022;29(7):1423–32. https://doi.org/10.1038/s41418-022-00931-2.
Koo BK, Stange DE, Sato T, Karthaus W, Farin HF, Huch M, et al. Controlled gene expression in primary Lgr5 organoid cultures. Nat Methods. 2011;9(1):81–3. https://doi.org/10.1038/nmeth.1802.
Li Z, Qian P, Shao W, Shi H, He XC, Gogol M, et al. Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion. Cell Res. 2018;28(9):904–17. https://doi.org/10.1038/s41422-018-0072-0.
Li Y, He Y, Peng J, Su Z, Li Z, Zhang B, et al. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Nat Cancer. 2021;2(1):49–65. https://doi.org/10.1038/s43018-020-00134-z.
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93–5. https://doi.org/10.1038/nchembio.1432.
Liu Y, Fan C, Zhang Y, Yu X, Wu X, Zhang X, et al. RIP1 kinase activity-dependent roles in embryonic development of Fadd-deficient mice. Cell Death Differ. 2017;24(8):1459–69. https://doi.org/10.1038/cdd.2017.78.
Liu T, Zheng X, Wang C, Wang C, Jiang S, Li B, et al. The m6A reader YTHDF1 promotes osteogenesis of bone marrow mesenchymal stem cells through translational control of ZNF839. Cell Death Dis. 2021;12(11):1078. https://doi.org/10.1038/s41419-021-04312-4.
Liu Y, Huang M, Wang X, Liu Z, Li S, Chen YG. Segregation of the stemness program from the proliferation program in intestinal stem cells. Stem Cell Rep. 2023;18(5):1196–210. https://doi.org/10.1016/j.stemcr.2023.03.007.
Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114(2):181–90. https://doi.org/10.1016/s0092-8674(03)00521-x.
Morral C, Ayyaz A, Kuo H-C, Fink M, Verginadis II, Daniel AR, et al. p53 promotes revival stem cells in the regenerating intestine after severe radiation injury. Nat Commun. 2024;15(1):3018. https://doi.org/10.1038/s41467-024-47124-8.
Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446(7135):557–61. https://doi.org/10.1038/nature05698.
Newton K, Wickliffe KE, Maltzman A, Dugger DL, Reja R, Zhang Y, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575(7784):679–82. https://doi.org/10.1038/s41586-019-1752-8.
Okumura R, Takeda K. Roles of intestinal epithelial cells in the maintenance of gut homeostasis. Exp Mol Med. 2017;49(5):e338. https://doi.org/10.1038/emm.2017.20.
Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9(11):778–88. https://doi.org/10.1038/nri2655.
Patankar JV, Becker C. Cell death in the gut epithelium and implications for chronic inflammation. Nat Rev Gastroenterol Hepatol. 2020;17(9):543–56. https://doi.org/10.1038/s41575-020-0326-4.
Qi Z, Li Y, Zhao B, Xu C, Liu Y, Li H, et al. BMP restricts stemness of intestinal Lgr5(+) stem cells by directly suppressing their signature genes. Nat Commun. 2017;8: 13824. https://doi.org/10.1038/ncomms13824.
Ruder B, Murtadak V, Stürzl M, Wirtz S, Distler U, Tenzer S, et al. Chronic intestinal inflammation in mice expressing viral flip in epithelial cells. Mucosal Immunol. 2018;11(6):1621–9. https://doi.org/10.1038/s41385-018-0068-6.
Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;20(19):2390–400. https://doi.org/10.1038/sj.onc.1204383.
Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4(5):E131–6. https://doi.org/10.1038/ncb0502-e131.
Silke J, Strasser A. The FLIP side of life. Sci Signal. 2013;6(258):pe2. https://doi.org/10.1126/scisignal.2003845.
Steinbrecher KA, Harmel-Laws E, Sitcheran R, Baldwin AS. Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J Immunol. 2008;180(4):2588–99. https://doi.org/10.4049/jimmunol.180.4.2588.
Sträter J, Möller P. Expression and function of death receptors and their natural ligands in the intestine. Ann N Y Acad Sci. 2000;915:162–70. https://doi.org/10.1111/j.1749-6632.2000.tb05239.x.
Subramanian S, Geng H, Tan XD. Cell death of intestinal epithelial cells in intestinal diseases. Sheng Li Xue Bao. 2020;72(3):308–24.
Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T, et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature. 2014;513(7516):95–9. https://doi.org/10.1038/nature13706.
Vlantis K, Wullaert A, Polykratis A, Kondylis V, Dannappel M, Schwarzer R, et al. NEMO prevents RIP kinase 1-Mediated epithelial cell death and chronic intestinal inflammation by NF-kappaB-dependent and -independent functions. Immunity. 2016;44(3):553–67. https://doi.org/10.1016/j.immuni.2016.02.020.
Wang S, Li S, Li Y, Jiang Q, Li X, Wang Y, et al. Non-muscle myosin heavy chain 9 maintains intestinal homeostasis by preventing epithelium necroptosis and colitis adenoma formation. Stem Cell Rep. 2021;16(5):1290–301. https://doi.org/10.1016/j.stemcr.2021.03.027.
Wang Y, Song W, Yu S, Liu Y, Chen YG. Intestinal cellular heterogeneity and disease development revealed by single-cell technology. Cell Regen. 2022;11(1):26. https://doi.org/10.1186/s13619-022-00127-6.
Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernández-Majada V, Ermolaeva M, et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature. 2011;477(7364):330–4. https://doi.org/10.1038/nature10273.
Xu K, Yang Y, Feng GH, Sun BF, Chen JQ, Li YF, et al. Mettl3-mediated m(6)a regulates spermatogonial differentiation and meiosis initiation. Cell Res. 2017;27(9):1100–14. https://doi.org/10.1038/cr.2017.100.
Xu D, Zou C, Yuan J. Genetic regulation of RIPK1 and Necroptosis. Annu Rev Genet. 2021;55:235–63. https://doi.org/10.1146/annurev-genet-071719-022748.
Yang H, Park SH, Choi HJ, Moon Y. Epithelial cell survival by activating transcription factor 3 (ATF3) in response to chemical ribosome-inactivating stress. Biochem Pharmacol. 2009;77(6):1105–15. https://doi.org/10.1016/j.bcp.2008.11.028.
Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20(1):19–33. https://doi.org/10.1038/s41583-018-0093-1.
Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608–24. https://doi.org/10.1038/s41580-019-0168-5.
Zhang T, Ding C, Chen H, Zhao J, Chen Z, Chen B, et al. M(6)a mRNA modification maintains colonic epithelial cell homeostasis via NF-κB-mediated antiapoptotic pathway. Sci Adv. 2022;8(12): eabl5723. https://doi.org/10.1126/sciadv.abl5723.
Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31–42. https://doi.org/10.1038/nrm.2016.132.
Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18–29. https://doi.org/10.1016/j.molcel.2012.10.015.
Zhou J, Edgar BA, Boutros M. ATF3 acts as a rheostat to control JNK signalling during intestinal regeneration. Nat Commun. 2017;8: 14289. https://doi.org/10.1038/ncomms14289.
Acknowledgements
We thank Drs. Wei Li, Xiaodong Wang and Sylvie Robine for mice. We thank Cell Biology Platform at Technology Center for Protein Sciences of Tsinghua University for preparation of TEM samples.
Funding
This work was supported by grants from the National Natural Science Foundation of China (31988101 to YGC, 92354306 to YL), the National Key Research and Development Program of China (2023YFA1800603), the Natural Science Foundation of Jiangxi Province (20224ACB209001), Beijing Science and Technology Plan (Z231100007223006), and Shenzhen Medical Research Fund (B2302022)to YGC.
Author information
Authors and Affiliations
Contributions
M. H., Y. L. and Y.-G. C. designed the experiments and wrote the manuscript. M. H. and Y. L. performed the experiments and analyzed the data. X. W., Y. L. and M. Z. did the bioinformatics analyses.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The experiments involving mouse were approved by the Institutional Animal Care and Use Committee (IACUC) of Tsinghua University.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests. Ye-Guang Chen is the Editor-in-Chief of Cell Regeneration. He was not involved in the review or the decision related to this manuscript.
Supplementary Information
13619_2024_197_MOESM1_ESM.docx
Additional file 1: Supplemental Information. Fig. S1. Ablation of Mettl3 induces cell death in the intestinal epithelium. Fig. S2. Inhibition of RIPK1 activity mitigates cell death in Mettl3-KO organoids. Fig. S3. Identification of transcriptional factors that regulate cell death in the intestinal epithelium. Fig. S4. Identification of ATF3 target genes that regulate cell death in Mettl3-KO organoids. Fig. S5. RIPK1 inactivation alleviates cell death in Mettl3-KO organoids and mice.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Huang, M., Wang, X., Zhang, M. et al. METTL3 restricts RIPK1-dependent cell death via the ATF3-cFLIP axis in the intestinal epithelium. Cell Regen 13, 14 (2024). https://doi.org/10.1186/s13619-024-00197-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13619-024-00197-8